The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon
Work +972 3 567 0700
Fax +972 3 566 0974

Dovev Apel

Work +972 3.5670876
S. Horowitz & Co

Work Department

Intellectual Property and Life Sciences.


Dovev is a highly experienced lawyer who advises major global and domestic pharmaceutical and technology-based companies on a wide range of intellectual property issues involving patents, trademarks, designs, copyrights, trade secrets, counterfeiting and brand management, with a particular strength in the life sciences industry. Dovev also has particular expertise advising on the full range of regulatory aspects relating to pharmaceuticals, life science products, medical devices and food supplements in Israel, including with regard to licensing, testing, manufacturing, Israeli Ministry of Health clearances, product registration, marketing, distribution and commercialisation, as well as product liability issues and class actions. On the contentious side, Dovev regularly appears before the Israel Patents, Designs and Trademarks Office, including in pre-grant patent opposition proceedings, and all levels of Israeli civil courts and arbitration tribunals on IP cases, including cross-border IP proceedings. He also represents clients in regulatory matters, particularly petitions to the High Court of Justice. Dovev's non-contentious practice includes advising on the commercial exploitation of intellectual property rights and IP legal due diligence within the context of M&A transactions, as well as the provision of legal opinions in the pharmaceutical field, in particular concerning issues of freedom to operate. Dovev actively contributes to the Israeli legislative process on matters relating to intellectual property and regulatory matters, for example, representing the Pharmaceutical Division of the Manufacturer's Association of Israel on the drafting of Israel's main piece of legislation regulating medical devices, and assisting the Israeli Ministry of Health in the preparation of regulations and guidelines concerning pharmaceutical products and medical devices.


Intern at the Jerusalem Magistrates Court and a teaching assistant in contract law at the Hebrew University (1999- 2000). Joined S. Horowitz & Co. in 2000. Partner (2007).


Hebrew and English.


Israel Bar Association AIPPI - The International Association for the Protection of Intellectual Property INTA - International Trademark Association


Hebrew University of Jerusalem, LL.B. cum laude (1999). Member of the Israel Bar (2001).


Healthcare and life sciences

Within: Healthcare and life sciences

S. Horowitz & Co has a broad-based IP practice, with specialists in the life sciences and pharmaceutical industries advising on a host of regulatory matters and IP litigation as well as cross-border commercial, licensing and distribution agreements. Demonstrative of the practice's breadth, the team advises Teva Pharmaceutical Industries on an array of regulatory issues, including drug and medical device registration, clinical trials and genetic testing, pharmaceutical legislation, and drug patent disputes. Dovev Apel and Tal Band act for The Chemical, Pharmaceutical, and Environmental Society of the Manufacturer's Association of Israel in relation to regulatory negotiations, compliance and disputes involving animal testing, freedom of information, pricing and IP. Other significant clients include Dexcel, Shire International, Humacyte, Allergan, Genmab, and Novocure. Moreover, the team advises Yeda Research and Development, the tech-transfer arm of The Weizmann Institute of Science, and has also handled inbound and outbound licensing transactions for an Israeli med-tech company. Dr Asaf Rentsler is another key contact in the department, which has recently added a number of new partners through a combination of promotions and lateral hires.

[back to top]

Intellectual property: disputes

Within: Intellectual property: disputes

S. Horowitz & Co is well known in every area of litigation in Israel and, in the IP space, has particular strengths in patent and trade mark disputes. The litigation practice is led by Tal Band, who handles a litany of patent opposition and patent infringement disputes for Teva, which is Israel's most active patent litigator. Band is also acting for Google and Waze Mobile in a patent infringement claim filed by an Israeli inventor. Additionally, Band, Dovev Apel and Yair Ziv acted for The Chemical, Pharmaceutical and Environmental Society of the Manufacturers' Association of Israel in a patent opposition claim against Takeda, which raised a fundamental question regarding patent term extensions. Another key figure in the department is Avi Ordo, who has particular expertise in multinational trade mark disputes, but also handles patent opposition proceedings. Ordo has handled trade mark opposition and infringement matters for client such as Sociedad Anónima Damm, NBC Universal and Allergan. Ran Vogel and Noam Blei are additional contacts in the department.

[back to top]

Back to index

Legal Developments in Israel

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to

    Accredited investor funding platforms for innovative tech scale-ups offer more choice and without having to commit a large chunk of capital upfront, the risk is diluted.
  • Perhaps the QuadragaCX Story Will Have a Happy Ending

    While there are the aficionados who will say that cryptocurrencies will free us of the chains of the global financial institutions, on the occasions when the world of cryptocurrencies intersects with the world in which most of us live, the news is generally bleak. While you may not know one side of a Bitcoin from the other, you probably know that its value has crashed over the last 13 months, you may even have heard about some of some of the larger cryptohacks (that is computer heists through which digital currencies belonging to investors are stolen from crypto trading exchanges). And over the last week or so, you may have read on mainstream news sites about the death of Gerald Cotton the CEO of Canada’s largest cryptoexchange QuadragaCX. The death of the CEO of a company that few had previously heard of, was news of course, because in his passing he had taken the passwords to the accounts of his customers with him. The result of this being that about $140 million of their money was stuck somewhere between this world and the celestial ether in which Mr. Cotton now resides. Of course, it wasn’t quite told like that. We were fed terms such as “private keys,” lack of “multi-signature protection,” “cold storage wallets” and more readily understandable – “cryptofraud”. Again!
  • Israel Chapter in The Virtual Currency Regulation Review

    Earlier this year, the Israel Tax Authority (ITA) issued two circulars, one on the taxation of digital tokens and the second addressing the taxation of utility tokens in initial coin offerings (ICOs). Additionally, in March, the Israel Securities Authority (ISA) released a detailed interim report by the Committee for the Regulation of Public Offerings of Decentralized Cryptocurrency Coins (Report) (with a follow-up report due to come out around October 2018). Moreover, it is expected that before the end of 2018, legislation will come into force that for the first time will see Israeli primary legislation define virtual currencies as financial assets and mandate licensing for related services, as is later discussed in detail.
  • Spring is coming for real estate registration in Israel

    Israel may be the “Start-up Nation” and a world-renowned center of technological innovation, yet for many years the procedures and conduct of the Israeli Land Registry have been trapped in the past.

    Israeli hi-tech and its sources of funding have grown and diversified tremendously since the bubble burst in 2001 and over the last decade since the height of the financial crisis in 2007-2008.

    Nondiscrimination has been the neglected stepchild of the FRAND commitment. Patent owners participating in standards organizations typically commit to license their technology on “fair, reasonable, and nondiscriminatory (“FRAND”) terms.”
  • Crash Course on Non-Disclosure Agreements

    Non-disclosure agreements are a crucial, but often overlooked, tool in allowing startup companies to grow, build strategic partnerships and explore new business relationships necessary to develop their product or bring it to market. These agreements are often short (sometimes only a page or two) and lead many founders to forego legal advice to get past this "formality" and begin working with the other party to the NDA. Yet, NDAs are important agreements with potentially far-reaching implications for the protection of a company's confidential information and intellectual property, and mishandling of NDAs can come back to haunt a startup years later.
  • Advocates Eli Greenbaum and Ezra Gross of Yigal Arnon & Co. in The Lawyer Special Report editorial

    An interview-style piece in The Lawyer, Law in Israel: moving beyond tech, quoting Eli Greenbaum and Ezra Gross:
  • Publication of Adv. Adrian Daniel's Commentary in Private Banker International on GDPR & Blockchain

    Publication of Adv. Adrian Daniel's Commentary in Private Banker International on GDPR & Blockchain.
  • Article in MEA Markets on GDPR & Israeli Law

    GDPR & ISRAELI PRIVACY LAW - KEY DIFFERENCES Yoheved Novogroder-Shoshan & Miriam Friedmann of Yigal Arnon & Co. outline the key differences between GDPR & Israeli Privacy Law.  mea_markets_-_gdpr__israeli_law_-_key_differences_14.05.2018